Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
Phase 1
Completed
- Conditions
- Diffuse Diabetic Macular Edema
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2012-03-22
- Lead Sponsor
- iCo Therapeutics Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00886808
- Locations
- 🇺🇸
Retina-Vitreous Associates Medical Group, Los Angeles, California, United States
🇺🇸Bascom Palmer Eye Institute, Miami, Florida, United States
🇺🇸Duke Eye Center, Durham, North Carolina, United States
News
No news found